|
This Package Insert is
provided for product evaluation purposes only and is
not intended to be used in place of the Package Insert shipped with the product.
RETRO-TEK
HIV-1
p24 Antigen ELISA
FOR RESEARCH USE
ONLY. NOT FOR in vitro DIAGNOSTIC USE.
| |
|
|
INTENDED
USE |
|
The RETRO-TEK HIV-1 p24 Antigen ELISA is supplied for research
purposes only. It is not intended for use in the diagnosis or
prognosis of disease, or for screening and may not be used as a
confirmatory test in diagnostic situations.
The RETRO-TEK HIV-1 p24
Antigen ELISA is an enzyme linked immunoassay used to detect Human
Immunodeficiency Virus Type 1 (HIV-1) p24 antigen in research
specimens, including cell culture media, as well as human sera and
plasma. It can also be used to monitor the purification and
biochemical behavior of HIV-1.
Furthermore, the assay may
augment or supplant reverse transcriptase measurements traditionally
employed to detect the presence of HIV-1. Such enzymatic
measurements are not HIV-1-specific.
The RETRO-TEK HIV-1 ICx/CRx
Kit (ZMC Catalog #: 0801096) for immune complex dissociation
and confirmation of p24 reactivity enhances the detection of p24
antigen in serum or plasma.
Many specimens contain HIV-1
viral loads greater than the range of the standard curve of this
assay. The RETRO-TEK HIV-1 p24 Extended Range ELISA (ZMC catalog #
0801137) will extend the standard curve of this assay to 4 ng/ml. |
| |
|
|
PRINCIPLE
OF THE TEST |
|
Microwells are
coated with a monoclonal antibody specific for the p24 gag
gene product of HIV-1. Viral antigen in the specimen is specifically
captured onto the immobilized antibody during specimen incubation.
The captured antigen is then reacted with a high-titered human
anti-HIV-1 antibody conjugated with biotin. Following a subsequent
incubation with Streptavidin-Peroxidase, color develops as the bound
enzyme reacts with the substrate. Resultant optical density is
proportional to the amount of HIV-1 p24 antigen present in the
specimen. |
| |
|
|
|
REAGENTS |
|
Materials
Supplied:
-
HIV-1 p24
Antibody Coated Microplate for 96 determinations,1 plate:
12x8 well strips.
-
HIV-1 p24
Detector Antibody, 1 vial, lyophilized: Contains
biotin-labeled human antibody to HIV-1, human source material
non-reactive for antibodies to HIV-1 and non-reactive for HIV-1
p24 antigen, milk, Triton X-100®, Tween 20®,
and PBS.
-
Detector
Antibody Diluent, 25 ml: Contains ProClin 300®.
-
HIV-1 p24
Antigen Standard, 0.5 ml: Contains detergent-disrupted,
heat-inactivated viral antigen, goat serum, Triton X-100®,
and sodium azide.
-
Lysing
Buffer, 5 ml: Triton X-100® in PBS and
2-chloroacetamide.
-
Streptavidin-Peroxidase, 0.3 ml: Contains streptavidin
conjugated to horseradish peroxidase, PBS, goat serum, and
2-chloroacetamide.
-
Assay
Diluent, 100 ml: Contains goat serum, PBS, Triton X-100®,
and 2-chloroacetamide.
-
10X Plate
Wash Buffer, 125 ml: Contains PBS, Tween 20®, and
2-chloroacetamide.
-
Substrate,
0.6 ml: Contains tetramethylbenzidine (TMB), and dimethyl
sulfoxide (DMSO).
-
Substrate
Buffer, 50 ml: Contains citrate/acetate buffer, hydrogen
peroxide, and 2-chloroacetamide.
-
Stop
Solution, 12 ml:
Proprietary formulation.
-
Plate
Sealers: 10
-
Resealable
Plastic Bag: 1
** Triton X-100® and ProClin 300®
are registered trademarks of Rohm and Haas. Tween 20® is
a registered trademark of Imperial Chemical Industries.
Storage:
Store all kit reagents at 2° -
8°C. DO NOT FREEZE. When stored properly the kit is stable until the
date indicated on the box label.
Materials Required but Not
Supplied:
- Validated adjustable
micropipettes, single and multichannel Test tubes and racks for
preparing specimen and control dilutions
- Graduated cylinders and
assorted beakers
- Validated automatic
microplate washer or manual vacuum
aspiration equipment
- Validated incubator for
37°C ±1°C
- Validated microplate
reader
- 1% sodium hypochlorite as
disinfectant. May be prepared from
household bleach
- Distilled or deionized
water
|
| |
|
|
|
PRECAUTIONS |
|
FOR RESEARCH USE ONLY.
NOT FOR in vitro DIAGNOSTIC USE.
- Prior to performing the assay, carefully
read all instructions.
- Use universal precautions when handling
kit components and test specimens.*
- To avoid cross-contamination, use
separate pipet tips for each specimen.
- When testing potentially-infectious human
specimens, adhere to all applicable local, state and federal
regulations regarding the disposal of biohazardous materials.
- HIV-1 p24 Antigen Standard contains
sodium azide as a preservative. Sodium azide may react with lead
or copper pipes to form explosive metal azides. Flush pipes with
large quantities of water upon disposal to prevent azide buildup
in drains.
- Stop Solution contains hydrochloric acid
which may cause severe burns. In case of contact with eyes or
skin, rinse immediately with water and seek medical assistance.
Wear protective clothing and eye wear.
Human source material used in the manufacture
of the HIV-1 Detector Antibody has been tested and found negative
for Hepatitis B surface antigen. The viral lysate used to prepare
the HIV-1 p24 Antigen Standard has been inactivated by chemical
disruption and heating. Handle these reagents as if capable of
transmitting infectious agents.
* MMWR, June 24,
1988, Vol. 37, No. 24, pp. 377-382, 387-388 |
| |
|
|
PREPARATION
OF REAGENTS |
|
HIV-1 p24
Detector Antibody: Add 11.0 ml of
Detector Antibody Diluent to the bottle of HIV-1
p24 Detector Antibody. Mix or rock gently for at least 1
hour. Reconstituted reagent can be stored for one week at 2 - 8°C.
Alternatively, the reconstituted HIV-1 p24 Detector Antibody can be
divided into aliquots and frozen at -20°C.
HIV-1 p24 Antigen Standard: Prepare a series of
six standards from the HIV-1 p24 Antigen Standard. Use the
dilution scheme in Table 1. Any diluted HIV-1 p24
Antigen Standard remaining after the completion of the assay should
be disinfected and discarded. Do not save diluted reagent.
Table 1
Preparation of HIV-1 p24 Antigen Standard
Standard
Number |
Concentration
of HIV-1 p24 (pg/ml) |
HIV-1 p24
Antigen
Standard (µl) |
Assay
Diluent (µl) |
| 1 |
125.0 |
50 |
950 |
| 2 |
62.5 |
500 of #1 |
500 |
| 3 |
31.3 |
500 of #2 |
500 |
| 4 |
15.6 |
500 of #3 |
500 |
| 5 |
7.8 |
500 of #4 |
500 |
| 6 |
0 |
0 |
500 |
Streptavidin-Peroxidase and Substrate: To prepare the
Streptavidin-Peroxidase Working Solution and the Substrate Working
Solution, use the dilution schemes in Table 2. Use Substrate
Working Solution within 15 minutes of its preparation. Any diluted
Substrate Working Solution and Streptavidin-Peroxidase Working
Solution remaining after the completion of the assay must be
discarded.
Table 2
Preparation of Streptavidin-Peroxidase Working
Solution
and Substrate Working Solution
|
|
Streptavidin-Peroxidase Working Solution |
Substrate
Working Solution |
|
Number of
Strips used |
Streptavidin-Peroxidase(µl) |
Assay Diluent
(ml) |
Substrate
(µl) |
Substrate
Buffer (ml) |
|
3 |
40 |
4.0 |
40 |
4.0 |
|
6 |
70 |
7.0 |
70 |
7.0 |
|
9 |
100 |
10.0 |
100 |
1.0 |
|
12 |
120 |
12.0 |
120 |
12.0 |
Plate Wash Buffer: Dilute 10X Plate Wash Buffer 1:10
in distilled or deionized water prior to use. 1X Plate Wash Buffer
may be stored at 2° - 8°C for up to 1 week. Additional bottles of
10X Plate Wash Buffer (ZMC Catalog # 0801060) may be ordered.
|
| |
|
|
TEST
PROCEDURE |
|
When
assaying serum or plasma samples, sensitivity may be increased by
using the RETRO-TEK HIV-1 p24 ICx/CRx Kit,
(ZMC Catalog #: 0801096) to dissociate possible immune complexes.
Reactive specimens should be confirmed using the ICx/CRx
Kit confirmatory reagents.
Allow all reagents to reach
room temperature before use. Label test tubes to be used for the
preparation of standards and specimens. Label each strip on its end
tab to identify the strips should they become detached from the
plate frame during the assay. If the entire 96 well plate will not
be used, remove surplus strips from the plate frame. Place surplus
strips and desiccant into the Resealable Plastic Bag, seal and store
at 2° - 8°C.
Step 1: Treat
specimens in a test tube by pipetting 50 µl of Lysing
Buffer into 450 µl specimen and mix well.
Step 2:
Wash each well of the microplate or the selected number of strips 6
times with 300 µl of 1X Plate Wash Buffer and aspirate.
Thoroughly blot by striking inverted microplate or strips on a pad
of absorbent towels. Continue striking until no droplets remain in
the wells. Do not allow washed plates to dry completely prior to
sample addition. Drying will adversely affect test results.
Step 3: Pipet
200 µl of standards #1-6 into duplicate wells. Leave
one well of the microtiter plate empty during the assay. This well
is used for a substrate blank.
Step 4: Pipet
200 µl of each specimen, as prepared in Step 1,
into duplicate wells.
Step 5:
Cover microplate with a plate sealer and incubate as follows:
Cover microplate with a plate sealer and incubate as follows:
a. Overnight at 37°C ±
1°C, for serum or plasma specimens treated with
RETRO-TEK HIV-1 ICx/CRx Kit.
b. Two hours at 37°C ±
1°C, for untreated serum or plasma, culture fluids or
other biological specimens.
Step 6:
Aspirate and wash plate as described in Step 2.
Step 7: Pipet
100 µl of reconstituted HIV-1 p24 Detector Antibody
into each well, except the substrate blank. Cover the microplate
with a sealer and incubate for 1 hour at 37°C ± 1°C.
Step 8:
Aspirate and wash plate as described in Step 2.
Step 9: Pipet
100 µl of the Streptavidin-Peroxidase Working Solution
into each well except the substrate blank. Cover the microplate with
a sealer and incubate for 30 minutes at 37°C ± 1°C.
Step 10:
Aspirate and wash plate as described in Step 2.
Step 11: Pipet
100 µl of Substrate Working Solution into all wells and
incubate uncovered for 30 minutes at room temperature
(18°- 25°C). A blue color will develop in wells containing
viral antigen.
Step 12: Stop
the reaction by pipetting 100 µl of Stop Solution into each
well. A color change from blue to yellow will result.
Step 13:
Within 15 minutes, read the optical density of each well at
450 nm using a microplate reader. |
| |
|
|
TEST
VALIDITY |
|
Determine the
mean optical density values for each standard and specimen. For the
test to be valid, it must meet the following criteria:
• The mean optical density of the 0 pg/ml standard and the substrate
blank
must be less than 0.100.
• The mean optical density of the 62.5 pg/ml standard must be
greater than
or equal to 0.500
Additional Validity Requirements for the RETRO-TEK HIV-1 ICx/CRx
Kit
• For immune complex dissociation, the positive control must be
above the
cut-off for immune complex dissociated specimens and the negative
control must be below the cut-off for immune complex dissociated
specimens.
• After treatment with the CRx Neutralization Reagent,
the level of the
Positive Control must be reduced by at least 50% and the level of
the
Negative Control must be below the cut-off. |
| |
|
|
|
CALCULATION
AND
INTERPRETATION OF RESULTS |
|
Determination
of the Cutoff Value:
A predetermined factor
is added to the mean of the negative control or negative specimen
sample optical value.
• For non-immune complex
dissociated serum or plasma samples, and tissue culture samples add
0.030.
• For immune complex
dissociated serum or plasma samples add 0.050.
The values above are
general guidelines to determine the cutoff value. Alternatively,
more accurate results may be obtained by adding at least two
standard deviations to the mean optical density from a set of known
negative specimen samples to establish the statistical cutoff value.
Samples with absorbance
values greater than or equal to the cutoff value are considered
positive. Positive results must be confirmed by retesting in
duplicate from the same sample source.
Specimens found to be
repeatedly reactive for p24 should be confirmed using the CRx
Neutralization
Procedure. Refer to Catalog #: 0801096 (RETRO-TEK ICx /CRx
Kit).
For confirmation of
reactivity by the RETRO-TEK ICx/CRx Kit,
calculate the percent reduction of p24 reactivity in controls and
specimens using the formula in Figure 1:

Reactivity is confirmed
by a reduction of p24 antigen in the specimen by 50% or greater. If
reactivity is not confirmed, the specimen is considered
indeterminate.
To Quantitate Levels
of HIV-1 p24 :
Using linear graph
paper, plot the concentration of HIV-1 p24 Antigen Standard (pg/ml)
on the X-axis versus the mean optical densities for each standard on
the Y-axis. Then determine the concentration of HIV-1 p24 antigen in
specimens by interpolation from the standard curve. Alternatively,
the level of HIV-1 p24 may be calculated by computer using a
point-to-point algorithm. Be sure to correct for all dilutions,
including the 1 to 1.1 dilution made during the addition of Lysing
Buffer.
TYPICAL STANDARD
CURVE
|
HIV-1
Antigen Concentration |
Avg. OD at
450nm in overnight assay* |
|
125.00
|
1.315
|
|
62.50
|
0.840
|
|
31.25
|
0.508
|
|
15.60
|
0.304
|
|
7.80
|
0.184
|
|
0.00
|
0.055
|
*2 hour assay values may be less
than the overnight results.
Standard curves may vary as a result of incubation time
and temperature, laboratory temperature, etc.
|
| |
|
|
LIMITATIONS
OF THE
PROCEDURE |
|
Most HIV-1
infected individuals produce antibodies to p24 antigen. The
concentration and microspecificity of these antibodies will vary
from individual to individual and from bleed to bleed. The observed
level of p24 antigen in any specimen containing p24 antibodies may
be affected by the following:
• Host antibodies may mask the
epitope reactive with capture MAb.
Consequently, the optical density may be reduced.
• Host antibodies may mask
epitopes that bind to the detector antibody,
again reducing the optical density.
After immune complex
dissociation and neutralization, host antibodies may recombine with
p24 antigen. The recombination of host antibody with antigen is
competitive with the capture of p24 by the MAb on the solid phase
and thus may mask some of the p24. The rate of recombination is
determined by the concentrations of p24 antigen and anti-p24
antibodies, the affinity of the antibodies, as well as temperature
and time and is therefore difficult to control. Correlation of
results for specimens between repeat test runs and among kits from
different manufacturers may be adversely affected by such
competetive recombination. |
| |
|
|
PROCEDURAL
FLOW CHART |
|
| |
PREPARE
REAGENTS |
|
| |
WASH PLATE |
|
| |
PIPET
SPECIMENS, STANDARDS AND CONTROLS |
|
FOR TREATED
SERUM OR PLASMA |
|
FOR UNTREATED
SERUM, PLASMA
AND OTHER
SPECIMENS |
|
INCUBATE
OVERNIGHT AT 37º + 1ºC |
|
INCUBATE 2 HOURS
AT 37º + 1ºC |
| |
WASH PLATE |
|
| |
PIPET
DETECTOR ANTIBODY |
|
| |
INCUBATE 1
HOUR AT AT 37º + 1ºC |
|
| |
WASH PLATE |
|
| |
PIPET
STREPTAVIDIN PEROXIDASE SOLUTION |
|
| |
INCUBATE 30
MINUTES AT AT 37º + 1ºC |
|
| |
WASH PLATE |
|
| |
PIPET
SUBSTRATE SOLUTION |
|
| |
INCUBATE 30
MINUTES AT ROOM TEMPERATURE |
|
| |
ADD STOP
SOLUTION AND READ AT 450 NM |
|
|
| |
|
|
Rev 08/05
|